|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
The US Bankruptcy Court conditionally approved the modified first amended plan and disclosure statement of PhaseBio Pharmaceuticals, Inc. on May 13, 2024. The debtor had filed its amended disclosure statement in the Court on May 13, 2024. May 13, 2024 has been fixed as voting record date.
The deadline to vote on the plan and the plan objection deadline is June 17, 2024. The confirmation hearing for the plan has been scheduled for June 26, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 49 | |
| +11.91% | 118B | |
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B |
PHASEBIO PHARMACEUTICALS, INC. 
